Jump to content

Indium (111In) satumomab pendetide

From Wikipedia, the free encyclopedia
(Redirected from Satumomab)
Indium (111In) satumomab pendetide
Monoclonal antibody
TypeWhole antibody
SourceMouse
TargetTAG-72
Clinical data
Other namesMAb B72.3-GYK-DTPA
ATC code
Identifiers
CAS Number
ChemSpider
  • none
UNII
 ☒NcheckY (what is this?)  (verify)

Indium (111In) satumomab pendetide (trade name OncoScint CR103) is a mouse monoclonal antibody which is used for cancer diagnosis.[1] The antibody, satumomab, is linked to pendetide, a derivative of DTPA. Pendetide acts as a chelating agent for the radionuclide indium-111.

References

[edit]
  1. ^ García-Fernández R, Luna-Pérez P, Hernández-Hernández DM, Iwasaki-Otake L, Pichardo-Romero P, Rodríguez-Ramirez S (2002). "[Usefulness of scintigraphy images with 111In-CYT-103 in the diagnosis of colonic and rectal recurrence]". Gaceta Médica de México. 138 (2): 139–44. PMID 12001423.
[edit]